NEET Practice Questions (MCQs) with Answers & Solutions

Practice free NEET NEET multiple-choice questions online with instant answers and detailed explanations. No login required.

All Physics Chemistry Botany Zoology
Register free to filter questions

Which of the following best describes 'Recombinant DNA technology' or 'Genetic engineering'?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

Modern biotechnology using genetically modified organisms was made possible only when man learnt to alter the chemistry of DNA and construct recombinant DNA. This key process is called recombinant DNA technology or genetic engineering.

What did scientists learn in the 1950s that paved the way for tissue culture techniques?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

It was learnt by scientists, during 1950s, that whole plants could be regenerated from explants, i.e., any part of a plant taken out and grown in a test tube, under sterile conditions in special nutrient media.

Transgenic animals are primarily used for which of the following purposes?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

Transgenic animals are also used to understand how genes contribute to the development of a disease by serving as models for human diseases, such as cancer, cystic fibrosis, rheumatoid arthritis.

Biotechnological processes applied in a restricted sense today commonly use:

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

However, it is used in a restricted sense today, to refer to such of those processes which use genetically modified organisms to achieve the same on a larger scale.

The conversion of an explant into a whole plant in tissue culture requires a nutrient medium that must provide:

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

It is important to stress here that the nutrient medium must provide a carbon source such as sucrose and also inorganic salts, vitamins, amino acids and growth regulators like auxins, cytokinins etc.

What is the primary benefit of recombinant therapeutics, such as human insulin produced in bacteria, over similar products isolated from non-human sources?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

Recombinant DNA technological processes have made immense impact in the area of healthcare by enabling mass production of safe and more effective therapeutics. Since the recombinant therapeutics are identical to human proteins, they do not induce unwanted immunological responses and are free from risk of infection as was observed in case of similar products isolated from non-human sources.

What was the primary disadvantage of using insulin extracted from slaughtered cattle and pigs for diabetic patients?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

The NCERT states: 'Insulin from an animal source, though caused some patients to develop allergy or other types of reactions to the foreign protein.'

Human insulin is synthesized as a pro-hormone. What key modification is required for it to become a mature and functional hormone?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

The NCERT states: 'In mammals, including humans, insulin is synthesised as a pro-hormone... which contains an extra stretch called the C peptide. This C peptide is not present in the mature insulin and is removed during maturation into insulin.'

What was the main challenge in producing mature human insulin using recombinant DNA techniques?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

The NCERT mentions: 'The main challenge for production of insulin using rDNA techniques was getting insulin assembled into a mature form.' This implies the difficulty in combining the A and B chains with their disulfide bonds.

Which company successfully developed and marketed genetically engineered human insulin in 1983?

You've reached today's free limit of 20 questions. Log in to keep practising for free.
Explanation

The NCERT states: 'In 1983, Eli Lilly an American company prepared two DNA sequences corresponding to A and B, chains of human insulin and introduced them in plasmids of E. coli to produce insulin chains.'

Ready to ace NEET?

Free access · No credit card required

Frequently Asked Questions

Yes. You can attempt every NEET question on this page for free without logging in, and check the correct answer with a detailed explanation instantly.

No account is required to attempt questions and view answers. A free account adds bookmarks, personal notes, and progress tracking.

The bank mixes NEET previous year questions (PYQs) with practice questions, each tagged with its exam appearances where applicable.